Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice. (Q51695717)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 2008

Language	Label	Description	Also known as
English	Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.	scientific article published in July 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

Mycobacterium tuberculosis

0 references

author name string

Juan Xu

1

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

Wenhuan Xu

2

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

Xia Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

Dan Zhao

4

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

Yingwei Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

language of work or name

0 references

publication date

1 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

26

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

35

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

4519-4525

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

ESAT-6 subunit vaccination against Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Comparative genomics of BCG vaccines by whole-genome DNA microarray

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Diagnosis of Mycobacterium tuberculosis infection using ESAT-6 and intracellular cytokine cytometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Modulating the immune response with dendritic cells and their growth factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Flt3 ligand (FL) and its influence on immune reactivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Regional, but not systemic recruitment/expansion of dendritic cells by a pluronic-formulated Flt3-ligand plasmid with vaccine adjuvant activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Enhancement of dendritic cell production by fms-like tyrosine kinase-3 ligand increases the resistance of mice to a burn wound infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

TB vaccines: progress and problems.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Dendritic cells as vectors for therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

The combination of plasmid interleukin-12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette-Guèrin) in protecting against systemic Mycobacterim avium infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Vaccine-induced immunity against Helicobacter pylori infection is impaired in IL-18-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Inhibition of natural type I IFN-producing and dendritic cell development by a small molecule receptor tyrosine kinase inhibitor with Flt3 affinity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

The prime-boost strategy: exciting prospects for improved vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Prime-boost strategies for malaria vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

DNA electroporation prime and protein boost strategy enhances humoral immunity of tuberculosis DNA vaccines in mice and non-human primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Increased levels of interferon-gamma primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Increased dendritic cell numbers impair protective immunity to intracellular bacteria despite augmenting antigen-specific CD8+ T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.06.044

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51695717&oldid=1368945434"